View of Diacerein : a New Class of Anti-Osteoarthritic Drugs

Study protocol for a randomised controlled trial of diacerein versus diacerein Diacerein 1% ointment was comparable to vehicle in study endpoints but did outperform vehicle when stratified by disease severity in the diacerein Diacerein helps relieve pain and inflammation associated with osteoarthritis (a condition where joint surfaces are damaged, causing pain and stiffness of the

diacerein Diacerein is a symptomatic slow-acting drug in osteoarthritis and the active metabolite is rhein It is a non-steroidal anti-inflammatory drug